13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001674546
申报总市值
US$47.5亿
US$47.5亿
176 檔
36.1%
Q4 2025 季度申报显示，Bellevue Group AG 披露的美股组合总市值为 US$47.5亿，涵盖 176 个不同之权益投资仓位。
Bellevue Group AG 在 Q4 2025 进行了结构性的板块轮动与仓位换股。在开立 37 个全新仓位及加仓 47 档持股的同时，亦同步清仓 9 档并减仓 83 档标的。
在资产配置集中度方面，Bellevue Group AG 的前 5 大核心持股（包含 RVMD, ARGX, IONS 等）合计占整体申报市值的 36.1%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 7.56% | +0.56% | -10.19% | |
| 2 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 7.36% | +0.44% | -15.46% | |
| 3 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 7.20% | -1.63% | -23.10% | |
| 4 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 5.85% | -1.20% | +34.66% | |
| 5 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 4.58% | +0.08% | -3.39% | |
| 6 | RNAGBP | Avidity Biosciences Inc | 股票-其他 | 3.60% | — | +22.21% | |
| 7 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.46% | -1.01% | -7.63% | |
| 8 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 3.39% | -1.36% | +25.03% | |
| 9 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 3.36% | -1.84% | -0.14% | |
| 10 | ABT | Abbott Laboratories | 股票-医疗保健 | 3.13% | -1.00% | -10.93% | |
| 11 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 2.90% | — | — | |
| 12 | BSX | Boston Scientific CORP | 股票-医疗保健 | 2.82% | -1.39% | -6.04% | |
| 13 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 2.57% | -0.53% | — | |
| 14 | SYK | Stryker CORP | 股票-医疗保健 | 2.40% | +0.08% | -20.07% | |
| 15 | NUVL | Nuvalent Inc-a | 股票-其他 | 1.98% | +0.17% | — | |
| 16 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 1.92% | -2.35% | +31174.62% | |
| 17 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.86% | +0.03% | +1.69% | |
| 18 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 1.84% | -0.15% | — | |
| 19 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.69% | -0.19% | +16.33% | |
| 20 | VERA | Vera Therapeutics Inc | 股票-其他 | 1.63% | -0.10% | — | |
| 21 | MDT | Medtronic plc | 股票-医疗保健 | 1.40% | -0.33% | +0.89% | |
| 22 | RLAY | Relay Therapeutics Inc | 股票-其他 | 1.34% | +0.59% | -0.00% | |
| 23 | IDXX | Idexx Laboratories Inc | 股票-医疗保健 | 1.21% | -0.51% | +23.44% | |
| 24 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.10% | +0.35% | +3.01% | |
| 25 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.07% | -0.01% | +7.80% | |
| 26 | PODD | Insulet CORP | 股票-医疗保健 | 1.01% | -0.41% | -11.94% | |
| 27 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 0.98% | -0.11% | -10.52% | |
| 28 | JBIO | Jade Biosciences Inc | 股票-其他 | 0.98% | +0.26% | — | |
| 29 | DHR | Danaher CORP | 股票-医疗保健 | 0.84% | -0.33% | +18.77% | |
| 30 | PEN | Penumbra Inc | 股票-医疗保健 | 0.80% | -0.10% | EXIT | |
| 31 | RMD | Resmed Inc | 股票-医疗保健 | 0.74% | -0.24% | -2.20% | |
| 32 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.72% | -1.15% | EXIT | |
| 33 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.71% | +0.09% | -38.71% | |
| 34 | MAZE | Maze Therapeutics Inc | 股票-其他 | 0.70% | — | — | |
| 35 | LLY | Eli Lilly & Co | 股票-医疗保健 | 0.69% | +0.01% | -16.07% | |
| 36 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 0.66% | -0.37% | -8.32% | |
| 37 | TNGX | Tango Therapeutics Inc | 股票-其他 | 0.66% | -0.73% | — | |
| 38 | ABBV | Abbvie Inc | 股票-医疗保健 | 0.58% | -0.27% | -21.08% | |
| 39 | CI | THE Cigna Group | 股票-医疗保健 | 0.57% | -0.23% | -10.18% | |
| 40 | GKOS | Glaukos CORP | 股票-医疗保健 | 0.56% | +0.01% | +368.36% | |
| 41 | JNJ | Johnson & Johnson | 股票-医疗保健 | 0.50% | -0.14% | +69.50% | |
| 42 | ANNX | Annexon Inc | 股票-其他 | 0.49% | -0.19% | — | |
| 43 | STE | STERIS plc | 股票-医疗保健 | 0.49% | -0.09% | -13.89% | |
| 44 | WVE | Wave Life Sciences Ltd. | 股票-其他 | 0.48% | — | EXIT | |
| 45 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.46% | +0.09% | -33.65% | |
| 46 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 0.45% | -0.16% | -0.10% | |
| 47 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 0.43% | -0.27% | -19.64% | |
| 48 | ALGN | Align Technology Inc | 股票-医疗保健 | 0.42% | -0.07% | -2.21% | |
| 49 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 0.41% | -0.10% | -2.66% | |
| 50 | MCK | Mckesson CORP | 股票-医疗保健 | 0.39% | -0.31% | -33.88% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | +2.2% | -10.19% | 减仓 |
| 2 | KRYS | Krystal Biotech Inc | +1.9% | +31174.62% | 加仓 |
| 3 | VRTX | Vertex Pharmaceuticals Inc | +1.7% | +34.66% | 加仓 |
| 4 | RNAGBP | Avidity Biosciences Inc | +1.7% | +22.21% | 加仓 |
| 5 | SRRK | Scholar Rock Holding CORP | +0.9% | +25.03% | 加仓 |
| 6 | GKOS | Glaukos CORP | +0.5% | +368.36% | 加仓 |
| 7 | RLAY | Relay Therapeutics Inc | +0.4% | -0.00% | 减仓 |
| 8 | EW | Edwards Lifesciences CORP | +0.2% | +16.33% | 加仓 |
| 9 | ISRG | Intuitive Surgical Inc | +0.2% | -7.63% | 减仓 |
| 10 | JNJ | Johnson & Johnson | +0.2% | +69.50% | 加仓 |
| 11 | IDXX | Idexx Laboratories Inc | +0.2% | +23.44% | 加仓 |
| 12 | DHR | Danaher CORP | +0.2% | +18.77% | 加仓 |
| 13 | ANNX | Annexon Inc | +0.2% | — | 不变 |
| 14 | MRK | Merck & Co. Inc. | +0.1% | +165.17% | 加仓 |
| 15 | INSP | Inspire Medical Systems Inc | +0.1% | +71.81% | 加仓 |
| 16 | CVS | Cvs Health CORP | +0.1% | +113.01% | 加仓 |
| 17 | LLY | Eli Lilly & Co | +0.1% | -16.07% | 减仓 |
| 18 | WAY | Waystar Holding CORP | +0.1% | +86.07% | 加仓 |
| 19 | GMED | Globus Medical Inc - A | 0% | -19.64% | 减仓 |
| 20 | ALGN | Align Technology Inc | 0% | -2.21% | 减仓 |
| 21 | ADPT | Adaptive Biotechnologies | 0% | +76.93% | 加仓 |
| 22 | PEN | Penumbra Inc | 0% | -7.83% | 减仓 |
| 23 | COO | Cooper Cos Inc/the | 0% | -0.10% | 减仓 |
| 24 | AVTR | Avantor Inc | 0% | +167.28% | 加仓 |
| 25 | BMY | Bristol-myers Squibb Co | 0% | +40.89% | 加仓 |
| 26 | REGN | Regeneron Pharmaceuticals | 0% | -7.50% | 减仓 |
| 27 | AMGN | Amgen Inc | 0% | +23.36% | 加仓 |
| 28 | TXG | 10x Genomics Inc-class A | 0% | +2.62% | 加仓 |
| 29 | PFE | Pfizer Inc | 0% | +380.65% | 加仓 |
| 30 | UTHR | United Therapeutics CORP | 0% | +47.54% | 加仓 |
| 31 | TEVA | Teva Pharmaceutical-sp Adr | 0% | -22.68% | 减仓 |
| 32 | GPCR | Structure Therapeutics Inc | 0% | -54.04% | 减仓 |
| 33 | BBNX | Beta Bionics Inc | 0% | +12.45% | 加仓 |
| 34 | BKD | Brookdale Senior Living Inc | 0% | +59.98% | 加仓 |
| 35 | NAMS | NewAmsterdam Pharma Company N.V. | 0% | +148.69% | 加仓 |
| 36 | BNTX | Biontech Se-adr | 0% | +28.86% | 加仓 |
| 37 | BBIO | Bridgebio Pharma Inc | 0% | +18.45% | 加仓 |
| 38 | ILMN | Illumina Inc | 0% | -3.60% | 减仓 |
| 39 | NVDA | Nvidia CORP | 0% | +460.26% | 加仓 |
| 40 | MDGL | Madrigal Pharmaceuticals Inc | 0% | +20.52% | 加仓 |
| 41 | MSFT | Microsoft CORP | 0% | +531.53% | 加仓 |
| 42 | AAPL | Apple Inc | 0% | +106.34% | 加仓 |
| 43 | CYTK | Cytokinetics Inc | 0% | +339.29% | 加仓 |
| 44 | AMZN | Amazon.com Inc | 0% | +95.42% | 加仓 |
| 45 | VKTX | Viking Therapeutics Inc | 0% | -9.75% | 减仓 |
| 46 | PTCT | Ptc Therapeutics Inc | 0% | +167.31% | 加仓 |
| 47 | CORT | Corcept Therapeutics Inc | 0% | +755.34% | 加仓 |
| 48 | GH | Guardant Health Inc | 0% | +53.81% | 加仓 |
| 49 | CNC | Centene CORP | — | -2.93% | 减仓 |
| 50 | GILD | Gilead Sciences Inc | — | +5.73% | 加仓 |
根据 SEC 官方 Form 13F 申报备案，Bellevue Group AG 在 Q4 2025 季度的美股持仓总市值约为 US$47.5亿，共申报了 176 个公开持股仓位。
在 Q4 2025 季度，Bellevue Group AG 按市值排列的前三大核心持股分别为：RVMD (7.6%)、ARGX (7.4%)、IONS (7.2%)。其中最大持股仓位 RVMD 占据整体投资组合约 7.6% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
AM6
市值: US$1.5亿
本季最大获利了结 / 清仓标的
AGIO
前期市值: US$1.5亿
在 Q4 2025 季度中，Bellevue Group AG 共进行了 176 项持仓异动，包含新建仓 37 个仓位、加仓 47 个仓位、减仓 83 个仓位以及清仓 9 个仓位。 其中最大新建仓标的为 AM6。 本季清仓仓位包含 AGIO。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。